BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35259714)

  • 1. HPLC-MS method for simultaneous quantification of the antiretroviral agents rilpivirine and cabotegravir in rat plasma and tissues.
    Ramöller IK; Abbate MTA; Vora LK; Hutton ARJ; Peng K; Volpe-Zanutto F; Tekko IA; Moffatt K; Paredes AJ; McCarthy HO; Donnelly RF
    J Pharm Biomed Anal; 2022 May; 213():114698. PubMed ID: 35259714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma.
    Bevers LAH; van Ewijk-Beneken Kolmer EWJ; Te Brake HML; Burger DM
    J Pharm Biomed Anal; 2024 Jan; 238():115832. PubMed ID: 37976991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma.
    Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A
    J Pharm Biomed Anal; 2017 May; 138():223-230. PubMed ID: 28219799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
    Courlet P; Alves Saldanha S; Cavassini M; Marzolini C; Choong E; Csajka C; Günthard HF; André P; Buclin T; Desfontaine V; Decosterd LA
    J Mass Spectrom; 2020 Jun; 55(6):e4506. PubMed ID: 32160389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots.
    Weld ED; Parsons TL; Gollings R; McCauley M; Grinsztejn B; Landovitz RJ; Marzinke MA
    J Pharm Biomed Anal; 2023 May; 228():115307. PubMed ID: 36842333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New HPLC-MS method for rapid and simultaneous quantification of doxycycline, diethylcarbamazine and albendazole metabolites in rat plasma and organs after concomitant oral administration.
    Permana AD; Tekko IA; McCarthy HO; Donnelly RF
    J Pharm Biomed Anal; 2019 Jun; 170():243-253. PubMed ID: 30947125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC-MS/MS and its application to a pharmacokinetic study.
    Prathipati PK; Mandal S; Destache CJ
    J Pharm Biomed Anal; 2016 Sep; 129():473-481. PubMed ID: 27497648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action.
    West RE; Oberly PJ; Saylor AJ; Riddler SA; Nolin TD; Devanathan AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124164. PubMed ID: 38823149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
    Aouri M; Calmy A; Hirschel B; Telenti A; Buclin T; Cavassini M; Rauch A; Decosterd LA
    J Mass Spectrom; 2013 May; 48(5):616-25. PubMed ID: 23674286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates.
    Date AA; Shibata A; Bruck P; Destache CJ
    Biomed Chromatogr; 2015 May; 29(5):709-15. PubMed ID: 25298145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue.
    Parsons TL; Marzinke MA
    J Pharm Biomed Anal; 2016 Nov; 131():333-344. PubMed ID: 27632783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV.
    Taki E; Soleimani F; Asadi A; Ghahramanpour H; Namvar A; Heidary M
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1135-1147. PubMed ID: 35596583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive HPLC-UV method for quantifying vancomycin in biological matrices: Application to pharmacokinetic and biodistribution studies in rat plasma, skin and lymph nodes.
    Ramadon D; Courtenay AJ; Permana AD; Tekko IA; McAlister E; McCrudden MTC; McCarthy HO; Donnelly RF
    J Pharm Biomed Anal; 2020 Sep; 189():113429. PubMed ID: 32593850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.
    Else L; Watson V; Tjia J; Hughes A; Siccardi M; Khoo S; Back D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1455-65. PubMed ID: 20427248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Evaluation of Dissolving Microarray Patches for Co-administered and Repeated Intradermal Delivery of Long-acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy.
    Moffatt K; Tekko IA; Vora L; Volpe-Zanutto F; Hutton ARJ; Mistilis J; Jarrahian C; Akhavein N; Weber AD; McCarthy HO; Donnelly RF
    Pharm Res; 2023 Jul; 40(7):1673-1696. PubMed ID: 36224503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
    Sengottuvelan S; Uppal R; Vuppu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a liquid chromatography-MS/MS method for simultaneous quantification of tenofovir and efavirenz in biological tissues and fluids.
    Barreiros L; Cunha-Reis C; Silva EMP; Carvalho JRB; das Neves J; Sarmento B; Segundo MA
    J Pharm Biomed Anal; 2017 Mar; 136():120-125. PubMed ID: 28073073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of rilpivirine in human plasma, cervicovaginal fluid, rectal fluid and genital/rectal mucosal tissues using liquid chromatography-tandem mass spectrometry.
    Else LJ; Tjia J; Jackson A; Penchala SD; Egan D; Boffito M; Khoo SH; Back DJ
    Bioanalysis; 2014; 6(14):1907-21. PubMed ID: 25158963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasma.
    Zheng Y; Aboura R; Boujaafar S; Lui G; Hirt D; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Gana I
    J Pharm Biomed Anal; 2020 Apr; 182():113119. PubMed ID: 32004775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an oral pharmacokinetic study.
    Mangla B; Alam O; Rub RA; Iqbal M; Singh A; Patel KS; Kohli K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122260. PubMed ID: 32679526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.